Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios
about
Bioresorbable vascular scaffolds technology: current use and future developmentsStent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish National RegistryClinical Outcomes of Bioresorbable Scaffold in Coronary Artery Disease: A Systematic Literature Review.Absorb bioresorbable stents for the treatment of coronary artery disease.Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian survey.Applicability and procedural success rate of bioresorbable -vascular scaffolds for percutaneous coronary intervention in an all-comer cohort of 383 consecutive patients.Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.Bioresorbable vascular scaffold implantation to bail out nail gun injury in ST-segment myocardial infarction.Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.Deliver the drug and be resorbed: evidence from ABSORB Japan.
P2860
Q26741147-C2CE735B-5CFB-41F9-B232-6BD714893BD4Q26785321-8F8BF60B-374A-47E1-BACF-05AE7C783B3BQ31106727-6DC6C74A-71F3-45B4-8E64-AB18AA8221E1Q35884429-8A79C29E-D727-4C90-B02B-DE8B3C87043EQ38573540-B8BC3A08-C5B5-4201-848F-06CF79FE0F98Q38813631-5901F0F9-9590-4CCA-A539-838F94A3BECAQ38824733-472EC67D-4E4F-47B8-A9C2-842AA17C9AF8Q40167885-3917B427-58B6-4BAC-8C61-EA564E0092A8Q47133838-A26C8BD0-0292-4CCE-8951-293660C653BDQ47927469-1505854D-D9FB-4850-AE07-EE64C1103001Q48949945-FB175F23-2407-4C30-B43E-614BC952A667Q50110037-DC5D449F-D9E8-47C1-9EE2-9FC45B6B83EBQ50663676-272EA12B-5E43-4F0B-ADFE-C24F8B2863F7Q51787529-D0D96954-746A-4076-891B-FD5D9BDD3BF8
P2860
Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Feasibility of second-generati ...... tomical and clinical scenarios
@ast
Feasibility of second-generati ...... tomical and clinical scenarios
@en
type
label
Feasibility of second-generati ...... tomical and clinical scenarios
@ast
Feasibility of second-generati ...... tomical and clinical scenarios
@en
prefLabel
Feasibility of second-generati ...... tomical and clinical scenarios
@ast
Feasibility of second-generati ...... tomical and clinical scenarios
@en
P2093
P2860
P1476
Feasibility of second-generati ...... tomical and clinical scenarios
@en
P2093
Catharina Anna Neumann
Christian Hagl
Christian Templin
Dana Roxana Bataiosu
Jelena-Rima Ghadri
Johanna Diekmann
Manuel Zipponi
Mia Aurelia Huber
Verena Geyer
P2860
P2888
P304
P356
10.1007/S00392-014-0757-4
P577
2014-08-31T00:00:00Z